Results 241 to 250 of about 89,205 (311)

A novel quinazolinone insulin receptor inhibitor and its synergy with an EGFR inhibitor in glucose‐driven glioblastoma

Molecular Oncology, EarlyView.
The novel styrylquinazolinone‐based molecule W1B effectively suppresses glioblastoma by inhibiting IGF1R and EGFR. In high‐glucose microenvironments driving tumor resistance, W1B acts synergistically with the EGFR inhibitor dacomitinib. This combination safely blocks compensatory survival signaling in zebrafish xenograft models. Showcasing promising in
Patryk Rurka, Wioleta Cieślik, Wojciech Płaziński, Katarzyna Stępnik, Anna Boguszewska‐Czubara, Elżbieta Kot, Robert Musioł, Mateusz Jasica, Anna Mrozek‐Wilczkiewicz, Katarzyna Malarz   +9 more
wiley   +1 more source

Global Study on Newborn HOspitalization and Parental Experiences (HOPE): rationale and design of a multinational cross-sectional mixed-methods online survey. [PDF]

BMJ Paediatr Open
Hoffmann J, Kemper R, Hummler H, Düzenli A, Zimmermann LJI, Mader S, Tischer C, HOPE Study Working Group.   +7 more
europepmc   +1 more source

Tumor B‐cell infiltration in platinum‐treated advanced muscle‐invasive urothelial carcinoma

Molecular Oncology, EarlyView.
Bladder tumors with higher pretreatment memory B‐cell infiltration were linked to longer survival after cisplatin chemotherapy, but not carboplatin. These tumors also showed more organized immune structures (tertiary lymphoid structures) and a shared pro‐inflammatory B‐cell‐rich community, suggesting that memory B cells may help identify patients most ...
Konrad Stawiski, Júlia Perera‐Bel, Alejo Rodriguez‐Vida, Nuria Juanpere, Jihyun Lee, Daniel E. Michaud, Jennifer L. Guerriero, Kent W. Mouw, Aristotelis Bamias, Filipe L. F. Carvalho, Joaquim Bellmunt   +10 more
wiley   +1 more source

Discomfort in the Unexpected: A Mixed-Methods Study on Australian Clinicians' Experiences of Explaining Prenatal Screening Results. [PDF]

Aust N Z J Obstet Gynaecol
Anderson MB, Cooke E, Thorpe K, Chawla JK.   +3 more
europepmc   +1 more source

Liquid biopsy‐based diagnostic evaluation of hypermethylated CpG sites for ovarian cancer diagnosis

Molecular Oncology, EarlyView.
This schematic outlines the workflow from biomarker identification to duplex MethyLight assay validation for epithelial ovarian cancer diagnosis using cfDNA‐based liquid biopsy. Initial screening of hypermethylated CpG candidates (cg02957270, cg10061138 cg00480298, COL2A1) was performed in tissue using ARMS‐PCR, COBRA, qPCR and image analysis. Selected
Deepa Bisht, Sameer Gupta, Amrita Chaurasia, Manisha Sachan   +3 more
wiley   +1 more source

Results from survey of research funding organisations

This deliverable reports the main results from the survey study of research funding ...
openaire   +1 more source

Weakening the nuclear envelope: Lamin B receptor in melanoma metastasis

Molecular Oncology, EarlyView.
LBR‐driven nuclear fragility supports melanoma invasion. A: Melanocyte presents low LBR (Lamin B Receptor) levels, maintaining nuclear integrity and lamina‐chromatin tethering. B: During malignant progression, upregulation of LBR clusters at the INM (Inner Nuclear Membrane) during confined migration causes local lamina weakening and cholesterol ...
Francesca Lorenzini, Maria Caterina Mione   +1 more
wiley   +1 more source

Co-creating a decision-making framework for primary healthcare models in conflict-affected Cameroon and Nigeria. [PDF]

BMJ Glob Health
Omam LA, Alain M, Wudiri Z, Moustapha CA, Nuraini A, Asimiya SS, O'Laughlin KN, Ambebe R, Alfred J, Jarman E, Martin S, Njingu AE, Musa I, Fuen FM, Choupo L, Andu L, Manuel S, Acha-Morfaw O, Fuh CE, Nicholas T, Idrissou M, Mohammed H, Van Bortel T, Parkes-Ratanshi R.   +23 more
europepmc   +1 more source

Can we enhance neurorehabilitation through regional implementation of group-based telerehabilitation? A mixed-methods evaluation of NeuroRehabilitation OnLine (NROL). [PDF]

BMJ Open
Ackerley S, Mason T, Partington A, Peel R, Vernon H, Connell L.   +5 more
europepmc   +1 more source

ASPIRE-Med project: a study protocol on an Australian psychotropic medicines training programme for disability support workers. [PDF]

BMJ Open
Barratt M, Speer K, Deb S, Bellon M, Cahalan T, Simpson A, Koncz R, Limbu B, Bushell M.   +8 more
europepmc   +1 more source